These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7138195)

  • 41. [Evaluation of the protective effects on the ischemic myocardium of coronary perfusion with perfluorochemicals (fluosol-DA)--a comparison with cold blood cardioplegia].
    Ishimaru S; Hirayama T; Uchino T; Hakoshima A; Hino H; Yamada M; Koike S; Furukawa K; Takahashi M; Yoshihama I
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Jan; 34(1):62-8. PubMed ID: 3711703
    [No Abstract]   [Full Text] [Related]  

  • 42. Protection by coenzyme Q10 of canine myocardial reperfusion injury after preservation.
    Matsushima T; Sueda T; Matsuura Y; Kawasaki T
    J Thorac Cardiovasc Surg; 1992 May; 103(5):945-51. PubMed ID: 1569776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of reperfusion after acute coronary occlusion on the beating, working heart compared to the arrested heart treated locally and globally with cardioplegia.
    Franco KL; Uretzky G; Paolini D; Milton G; Cohn LH
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):561-6. PubMed ID: 6608639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reperfusate composition: supplemental role of intravenous and intracoronary coenzyme Q10 in avoiding reperfusion damage.
    Okamoto F; Allen BS; Buckberg GD; Leaf J; Bugyi H
    J Thorac Cardiovasc Surg; 1986 Sep; 92(3 Pt 2):573-82. PubMed ID: 3747585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of crystalloid cardioplegia and verapamil on cardiac function and cellular biochemistry during hypothermic cardiac arrest.
    Prasad K; Bharadwaj B
    Can J Cardiol; 1987 Sep; 3(6):293-9. PubMed ID: 2962703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular indices of apoptosis after intermittent blood and crystalloid cardioplegia.
    Feng J; Bianchi C; Sandmeyer JL; Li J; Sellke FW
    Circulation; 2005 Aug; 112(9 Suppl):I184-9. PubMed ID: 16159813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart.
    Coetzee A; Kotzé J; Louw J; Lochner A
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):259-69. PubMed ID: 3945093
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of myocardial protection during blood-potassium cardioplegia: a comparison of crystalloid red cell and methemoglobin solutions.
    Bing OH; LaRaia PJ; Franklin A; Stoughton J; Weintraub RM
    Circulation; 1984 Sep; 70(3 Pt 2):I84-90. PubMed ID: 6744572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cardioplegia].
    Yamada T
    Kokyu To Junkan; 1983 Feb; 31(2):165-72. PubMed ID: 6346439
    [No Abstract]   [Full Text] [Related]  

  • 50. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
    Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
    Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is blood versus crystalloid cardioplegia relevant? Significantly improved protection may require new cardioplegic concepts!
    Fallouh HB; Chambers DJ
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1162-3. PubMed ID: 18784121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Myocardial protection: some problems and recent progress].
    Abe T
    Kyobu Geka; 1991 Dec; 44(13):1098-103. PubMed ID: 1758121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of myocardial metabolism with microdialysis during bypass surgery with cold blood- or Calafiore cardioplegia.
    Pöling J; Rees W; Mantovani V; Klaus S; Bahlmann L; Ziaukas V; Hübner N; Warnecke H
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):597-603. PubMed ID: 16901714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Myocardial protection of cold autoblood cardioplegia in infants with congenital heart disease].
    Zhang Q; Meng BY; Peng L; Wang T; Ma C; Tao J
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):638-40. PubMed ID: 19695188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An experimental study of myocardial protection with special reference to cold blood potassium cardioplegia: I. Morphological and biochemical studies.
    Shiraishi Y
    Nihon Geka Hokan; 1983 Jul; 52(4):435-66. PubMed ID: 6660986
    [No Abstract]   [Full Text] [Related]  

  • 56. Crystalloid versus cold blood cardioplegia and cardiac troponin I release.
    Pichon H; Chocron S; Alwan K; Toubin G; Kaili D; Falcoz P; Latini L; Clement F; Viel JF; Etievent JP
    Circulation; 1997 Jul; 96(1):316-20. PubMed ID: 9236451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antegrade versus retrograde crystalloid cardioplegia: perioperative assessment of cardiac energy metabolism by means of myocardial lactate measurement.
    Noyez L; Verhagen AF; Lacquet LK
    Thorac Cardiovasc Surg; 1995 Aug; 43(4):194-9. PubMed ID: 7502281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Enhanced myocardial protection by crystalloid cardioplegia at 4 degrees centigrade].
    Yano Y
    Nihon Kyobu Geka Gakkai Zasshi; 1983 Nov; 31(11):2027-36. PubMed ID: 6672122
    [No Abstract]   [Full Text] [Related]  

  • 59. [Application of microfluorometry to cardiovascular surgery. I. Evaluation of the viability of myocardium by microfluorometry (author's transl)].
    Chiba Y
    Nihon Geka Hokan; 1982 Mar; 51(2):307-14. PubMed ID: 7115005
    [No Abstract]   [Full Text] [Related]  

  • 60. [The experimental study of oxygenated crystalloid cardioplegia assessed by intramyocardial PCO2 monitoring].
    Watanabe T; Inoue K; Murata N; Horiuchi M; Yokokawa H; Nomoto S; Takaba T; Ishii J
    Nihon Kyobu Geka Gakkai Zasshi; 1988 Aug; 36(8):1238-44. PubMed ID: 3142954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.